Adoption of Biosimilars: Prescriber, Pharmacy and Payer Perspectives

This activity is supported by educational funding provided by Amgen and Merck Sharp & Dohme Corp.

On-demand 4-part Medical Crossfire

Adoption of Biosimilars: Prescriber, Pharmacy and Payer Perspectives

Activity Overview

This 4-part online CE-accredited activity will serve as an update on the clinical options in Biosimilars and the changing environment for clinicians, specialty pharmacists, and payers. To view each activity, click on the hyperlinks below.

Part 1: Overview of the Biosimilar Review Process: Evaluating Biosimilar Safety, and Bioequivalence

Part 2: Clinical Adoption of Biosimilars: Prescriber Viewpoint

Part 3: A Managed Care and Population Health Perspective of Biosimilars

Part 4: Access to Biosimilars: The Role of the Specialty Pharmacy